Loading clinical trials...
Loading clinical trials...
Effect of Prior Therapy With Nilotinib or Dasatinib on the Outcome After Allogeneic Stem Cell Transplantation for Patients With Chronic Myeloid Leukaemia
Conditions
Locations
10
Denmark
Rigshospitalet
Copenhagen, Denmark
Helsinki University Central Hospital
Helsinki, Finland
University of Freiburg
Freiburg im Breisgau, Germany
University of Muenster
Münster, Germany
St Ivan & St Laszlo Hospital
Budapest, Hungary
Chaim Sheba Medical Centre
Tel Litwinsky, Israel
Start Date
January 1, 2010
Primary Completion Date
March 19, 2014
Completion Date
September 29, 2017
Last Updated
February 20, 2024
NCT06119269
NCT02467270
NCT01660607
NCT04126681
NCT06516029
NCT05638763
Lead Sponsor
European Society for Blood and Marrow Transplantation
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions